A partnership that benefits patients
What is a clinical trial and how to participate.
Look at our future science
Review our clinical pipeline
What is a clinical trial and how to participate
Millions of people with diabetes use our products every day, but too many still struggle to afford their medicine and get access to treatment.
Find answers to some of the more frequently asked questions on sustainability and responsible business practices.
Being transparent and accountable about how we operate ensures we meet legal requirements, improve how we conduct our business and increase our positive impact.
Novo Nordisk files annual report with the SEC ... Read more
Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased b ... Read more
Staten Biotechnology B.V. and Novo Nordisk A/S announce collaboration to develop ... Read more
Oral semaglutide demonstrates favourable cardiovascular safety profile and signi ... Read more
Trading in Novo Nordisk shares by board members, executives and associated perso ... Read more
Novo Nordisk A/S - Share repurchase programme ... Read more
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives an ... Read more
Annual General Meeting, Copenhagen
Financial statement for the first three months of 2019,
Financial statement for the first six months of 2019,
Financial statement for the first nine months of 2019,
Take an advanced view of the Novo Nordisk share
Click here to find further information
Link to conference call and presentation
Read about Novo Nordisk – A focused healthcare company
See relevant content for private investors
Download relevant Investor Relations material
Peter Hugreffe AnkersenHead of Investor Relations
Anders Mikkelsen Investor Relations Manager
Valdemar Borum Svarrer Investor Relations Manager
Kristoffer Due Berg Investor Relations Manager
Ann Søndermølle Rendbæk Investor Relations Manager
Chilie Thomsen Investor Relations Coordinator
Sign up to receive company announcements.
Link to webcast and presentation
